Acetate derived from prebiotic fermentation in the gut lumen regulates hepatic lipid metabolism and insulin sensitivity via FFAR2 in hepatocytes, which prevents the progression of NAFLD/NASH (Fig. 7). The gene discussed is FFAR2; the disease is metabolic dysfunction-associated steatotic liver disease.